OncoZenge AB Stock: price and insider trades · Sweden
2 insiders bought €44k of shares over the last 90 days, the latest by Per Daniel Ehrenstråhle, filed 24 Sept 2026.
OncoZenge AB: what insiders have been doing
OncoZenge AB belongs to the Health Care sector. Filings by its managers are published through Finansinspektionen. Over the twelve months to 29 October 2026, 8 filings were filed, from 3 insiders.
Every open-market trade in the period is a purchase: 4 purchases worth €80k, from 3 insiders, and not a single sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 2 board members and 1 chief executive among the declarants. Stian Kildal filed the largest purchase, €36k, on 28 November 2025, which represents 0.41% of the company's market value.
Across the 1,031 companies tracked on its exchange, the median is 9 filings; at 8 filings, this issuer sits below that mark. Since 2021, the database holds 8 purchases and no sales by insiders of the company.
The most recent open-market purchase was published on 24 September 2026, 44 days ago. The median gap between a trade and its publication by Finansinspektionen is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleFinancial data
as of FY 2025FY ended December 2025 · cache
- 118,500 shares@ SEK 3.0064.0% of flowBTA (betald tecknad aktie)ISIN SE0015504097FI:csv-b298d54d21e919281ae0
- 375,000 shares@ SEK 3.0055.3% of flowBTA (betald tecknad aktie)ISIN SE0030264628FI:csv-b94a399a5300347739b4
- 100,000 shares@ SEK 3.0058.7% of flowBTA (betald tecknad aktie)ISIN SE0030264628FI:csv-4794123c9b967d25fee3Canonical exit: 22 Dec 2026 (T+90)
- 1,000,000 shares@ SEK 0.20710.4% of flowTeckningsoptionFI:csv-7fec5a8a7cc35f704a73
- 1,000,000 shares@ SEK 0.20741.3% of flowTeckningsoptionFI:csv-2661306bb9c361952e04
- 20,000 shares@ SEK 5.050.12% mcap18.5% of flowAktieISIN SE0015504097FI:csv-3669c09e81f729583754Canonical exit: 26 Nov 2026 (T+90)
- 18,000 shares@ SEK 5.300.11% mcap17.5% of flowAktieISIN SE0015504097FI:csv-e1e9e5c0bdfb135d51c9Canonical exit: 25 Nov 2026 (T+90)
- 74,999 shares@ SEK 5.300.41% mcap20.2% of flowAktieISIN SE0015504097FI:A003U252-1Canonical exit: 26 Feb 2026 (T+90)
- 25,000 shares@ SEK 6.300.16% mcap8.0% of flowAktieISIN SE0015504097FI:A003S148-1Canonical exit: 8 Dec 2025 (T+90)
- 20,000 shares@ SEK 5.910.12% mcap6.1% of flowAktieISIN SE0015504097FI:A003N025-2Canonical exit: 26 Jun 2025 (T+90)
- 10,633 shares@ SEK 10.25100.0% of flowAktieISIN SE0015504097FI:csv-041d73ab1f4e5574e6f3
- 15,000 shares@ SEK 10.25100.0% of flowBTA (betald tecknad aktie)ISIN SE0015531231FI:A001R016-1
- 14,635 shares0Teckningsrätt/UniträttISIN SE0015531223FI:csv-49041f47dc775153a4dcCanonical exit: 20 May 2021 (T+90)
- 14,635 shares0Teckningsrätt/UniträttISIN SE0015504097FI:csv-0708ab0967f92dfb71efCanonical exit: 20 May 2021 (T+90)
14 of 14 declarations
About OncoZenge AB
OncoZenge AB is a company focused on developing innovative cancer treatments. It is listed on the XSTO stock exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
